4
Changes in Ownership
IRONWOOD PHARMACEUTICALS INC Filed Acc 0000950170-24-029910
SVP, Chief Business Officer acquired 37,120 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Davis Andrew SVP, Chief Business Officer | 2024-03-08 | Option exercise | +37,120 | 310,756 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Davis Andrew SVP, Chief Business Officer | 2024-03-08 | Option exercise · Performance-based Restricted Stock Unit | −37,120 | 0 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…